LMG Life Sciences Awards EMEA 2024: open for nominations

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2024: open for nominations

Copy of EMEA awards 2024-Shortlist Announced-1200x627.png

The EMEA region research cycle has commenced - do not miss this opportunity to nominate your work from 2023!

The EMEA region research cycle has commenced – do not miss this opportunity to nominate your work from 2023!

The LMG Life Sciences is excited to announced the launch of the 2024 research. We continue to recognise the top firms, lawyers, and legal work serving the Life Sciences industry from throughout the Europe, Middle East, & Africa region.

The deadline for nominations is 25 January 2024.

You can find detailed information about the awards by downloading the methodology, or reading the FAQs and the full list of categories on the LMG Life Sciences website.

Important Dates:

Nominations Open

Nominations Close

Shortlist Published

Gala Ceremony

8 December 2023

25 January 2024

March 2024

May 2024


All nominations to the awards must be entered through our dedicated nomination gateway. Nominations made in any other format or emailed to us will not be accepted.

For any questions about the awards or the research, please contact research editor, John Harrison.

For queries about business development and commercial opportunities, please contact George Reeves.

LMG Life Sciences Awards

The LMG Life Sciences awards look to recognise leading law firms and lawyers specialised in the life sciences industry throughout the Europe, Middle East, and Africa region. The awards ceremony will take place to celebrate outstanding legal work over the previous calendar year. The awards ceremony aims to honour firms and attorneys on the forefront of legal work in life sciences. The award’s distinctive structure highlights firms that specialise in practice areas within the life sciences industry by shortlisting firms and by listing our life sciences nominees in a way that shows overlap between certain legal areas.


Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IP Stars research.

more from across site and SHARED ros bottom lb

More from across our site

Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
The initial contempt of court claim targeted Stobbs and the firm’s client for allegedly interfering with the administration of justice
Acquisition of platform developed by Boehmert & Boehmert lawyer set to create a combined platform for patent drafting and prosecution in Europe
Partner Rob Jacob unveils plans to offer a beginning-to-end trademark service, how to make prosecution profitable, and why IP ‘buy-in’ from the CEO stands the firm in good stead
Sponsored by CAS
CAS provides practical pointers on how intellectual property and R&D teams can work in tandem to unlock tangible benefits and avoid wasted spend
Sponsored by CAS
CAS explores how AI is transforming intellectual property, from inventorship and copyright disputes to new demands on patent attorneys
Sponsored by That.Legal
Gillian Tan of That.Legal discusses a recent decision by the Intellectual Property Office of Singapore and what it reveals about the evidential burden in bad-faith trademark claims
Attorneys at Di Blasi, Parente & Associados share how the protection of trade secrets strengthens innovation by bringing together legal practice, regulatory developments, and established international references
Jin Ooi, who joins as a partner today, said he is excited to offer a ‘rounded’ IP service as the firm deepens its litigation expertise in the UK and Europe
As generics celebrate, practitioners believe innovator companies should brace for an ‘uphill battle’ when trying to prove induced infringement
Gift this article